DL-Propargylglycine (CAS 64165-64-6)
QUICK LINKS
DL-Propargylglycine is a versatile compound utilized in biochemical and chemical synthesis research. Its presence in studies often relates to the inhibition of enzymes, such as cystathionine gamma-lyase, which are involved in the metabolism of amino acids like cysteine. The propargyl moiety of DL-Propargylglycine serves as a key functional group in the design of enzyme inhibitors due to its ability to interact with the active sites of enzymes. Additionally, this compound is used in the field of organic synthesis, where it can be employed as a non-natural amino acid in the preparation of peptidomimetics and other modified peptides. Its alkyne group is particularly useful in click chemistry reactions, which are widely applied in the development of new materials and bioconjugation techniques. Researchers also investigate the incorporation of DL-Propargylglycine into proteins to study protein function and to produce proteins with altered properties for industrial applications.
DL-Propargylglycine (CAS 64165-64-6) References
- Effects of mushroom toxins on glycogenolysis; comparison of toxicity of phalloidin, alpha-amanitin and DL-propargylglycine in isolated rat hepatocytes. | Kawaji, A., et al. 1992. J Pharmacobiodyn. 15: 107-12. PMID: 1320679
- Propargylglycine inhibits hypotaurine/taurine synthesis and elevates cystathionine and homocysteine concentrations in primary mouse hepatocytes. | Jurkowska, H., et al. 2015. Amino Acids. 47: 1215-23. PMID: 25772816
- Hydrogen sulfide promotes adipogenesis in 3T3L1 cells. | Tsai, CY., et al. 2015. PLoS One. 10: e0119511. PMID: 25822632
- DL-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats. | Oosterhuis, NR., et al. 2015. Nitric Oxide. 49: 56-66. PMID: 26192363
- DL-Propargylglycine protects against myocardial injury induced by chronic intermittent hypoxia through inhibition of endoplasmic reticulum stress. | Zhou, X., et al. 2018. Sleep Breath. 22: 853-863. PMID: 29770919
- H2S mediates carotid body response to hypoxia but not anoxia. | Peng, YJ., et al. 2019. Respir Physiol Neurobiol. 259: 75-85. PMID: 30086385
- Endogenous hydrogen sulfide improves vascular remodeling through PPARδ/SOCS3 signaling. | Tian, D., et al. 2021. J Adv Res. 27: 115-125. PMID: 33318871
- Hydrogen sulfide alleviates apoptosis and autophagy induced by beryllium sulfate in 16HBE cells. | Liu, YP., et al. 2022. J Appl Toxicol. 42: 230-243. PMID: 34091916
- Contents of cystathionine and taurine in various cerebellar regions of DL-propargylglycine-treated rats. | Kodama, H., et al. 1988. J Neurochem. 51: 1046-8. PMID: 3418343
- L-methionine catabolism in trichomonads. | Thong, KW., et al. 1987. Mol Biochem Parasitol. 23: 223-31. PMID: 3496535
- Protective role of hydrogen sulfide against diabetic cardiomyopathy via alleviating necroptosis. | Gong, W., et al. 2022. Free Radic Biol Med. 181: 29-42. PMID: 35101564
- Role of hydrogen sulfide in sulfur dioxide production and vascular regulation. | Sun, C., et al. 2022. PLoS One. 17: e0264891. PMID: 35298485
- Cystathionine γ-lyase mediates cell proliferation, migration, and invasion of nasopharyngeal carcinoma. | Zhang, Q., et al. 2022. Oncogene. 41: 5238-5252. PMID: 36310322
- NaHS restores the vascular alterations in the renin-angiotensin system induced by hyperglycemia in rats. | Silva-Velasco, DL., et al. 2023. Peptides. 164: 171001. PMID: 36990388
- Cystathionine accumulation in various regions of brain of DL-propargylglycine-treated rats. | Kodama, H., et al. 1985. J Neurochem. 44: 1207-9. PMID: 3973610
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DL-Propargylglycine, 1 g | sc-294408 | 1 g | $172.00 | |||
DL-Propargylglycine, 5 g | sc-294408A | 5 g | $692.00 |